A good prognosis of endocrine-dependent tumors among residual invasive cancer after anti-HER2 therapy: CALGB 40601 (Alliance) and validation studies
      Google Scholar   
Citation:
Cancer Res vol 81 (4 Supplement) PS10-02
Meeting Instance:
SABCS 2020
Year:
2020
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
Yes
DataSharing:
No
SDC:
No
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
GSK  
Grants:
U10CA180821, U10CA180882, U24CA196171, U10CA180888, U10CA180818, U10CA180801, P50-CA58223-09A1, R01-CA195740, R01CA229409, P30 CA008748  
Corr. Author:
 
Authors:
                               
Networks:
ALLIANCE, LAPS-NC007   
Study
CALGB-40601
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: